Tuberculosis

New paper: Review on NSAIDS for TB

Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional tuberculosis treatment, complicated by emerging drug resistances. We have been working on Host-directed therapies, mainly in non-steroidal anti-inflammatory drugs (NSAIDs), since 2010.  In collaboration with our colleagues from the University Medical Center Groningen and the HDT-Network, we have just published in Frontiers Immunology Journal a  Systematic Review in which investigate whether NSAIDs display any effects as therapy of TB. We have included ten studies, seven preclinical studies in mice and three clinical trials. Our results point toward a beneficial effect of NSAIDs as adjunct to current TB therapy regimens, even if the determination of the best timing for their administration needs further investigation.

You can read and download the paper here.


Source Link


DISCLAIMER

This blog is for information purposes only. The content is not intended as medical advice, diagnosis, or treatment. Should you have a medical or dermatological problem, please consult with your physician. None of the information or recommendations on this website should be interpreted as medical advice.

All product reviews, recommendations, and references are based on the author’s personal experience and impressions using the products. All views and opinions are the author’s own.

This blog post may contain affiliate links. An affiliate link means we may earn a commission if you click on a link and make a purchase, without any extra cost to you.

Please see our Disclaimer for more information.

odiseases.com

diseases, diagnosis and treatment methods, drugs and their side effects on this site. online diseases, diagnosis and treatment methods

Related Articles

Back to top button
%d bloggers like this: